A Novel Framework Integrating AI Model and Enzymological Experiments Promotes Identification of SARS-CoV-2 3CL Protease Inhibitors and Activity-based Probe
원문 초록
The identification of protein-ligand interaction plays a key role in biochemical research and drug discovery. Although deep learning has recently shown great promise in discovering new drugs, there remains a gap between deep learning-based and experimental approaches. Here we propose a novel framework, named AIMEE, integrating AI Model and Enzymology Experiments, to identify inhibitors against 3CL protease of SARS-CoV-2, which has taken a significant toll on people across the globe. From a bioactive chemical library, we have conducted two rounds of experiments and identified six novel inhibitors with a hit rate of 29.41%, and four of them showed an IC50 value less than 3 {\mu}M. Moreover, we explored the interpretability of the central model in AIMEE, mapping the deep learning extracted features to domain knowledge of chemical properties. Based on this knowledge, a commercially available compound was selected and proven to be an activity-based probe of 3CLpro. This work highlights the great potential of combining deep learning models and biochemical experiments for intelligent iteration and expanding the boundaries of drug discovery.
함께 살펴볼 논문
공통 태그를 근거로 연결했습니다. 실제 인용 관계나 논문의 우수성을 뜻하지 않습니다.
B-XAIC Dataset: Benchmarking Explainable AI for Graph Neural Networks Using Chemical Data
Assay2Mol: large language model-based drug design using BioAssay context
PocketVina Enables Scalable and Highly Accurate Physically Valid Docking through Multi-Pocket Conditioning
Fast Bayesian Optimization of Function Networks with Partial Evaluations
Robust Molecular Property Prediction via Densifying Scarce Labeled Data
MTPNet: Multi-Grained Target Perception for Unified Activity Cliff Prediction
토론
이 논문과 연결된 포럼 글이 아직 없습니다.